Research indicates hospitals contribute to the local spread of antibiotic-resistant infections.
A recent study published in the journal Infection Control & Hospital Epidemiology by the Society for Healthcare Epidemiology of America suggests that family members of patients discharged from hospitals may be at an increased risk of contracting antibiotic-resistant infections, commonly referred to as superbugs. This risk persists even if the patient themselves was not diagnosed with such an infection, indicating that hospitals may contribute to the spread of resistant bacteria in the community.
When recently hospitalized patients were diagnosed with the superbug — Methicillin-resistant Staphylococcus aureus infection (MRSA) — the risk to relatives living with them was even higher. The longer the relative's hospital stay, even without a MRSA diagnosis, the higher the risk to family members.
"Patients can become colonized with MRSA during their hospital stay and transmit MRSA to their household members," said Aaron Miller, PhD, lead researcher on the study and research assistant professor of internal medicine-infectious diseases at the University of Iowa. "This suggests hospitals contribute to the spread of MRSA into the community through discharged patients who are asymptomatic carriers."
Recommendations for Hospitals
Miller recommends hospitals enhance infection control practices, including testing for MRSA colonization, especially at discharge, even with there are no symptoms of infection. He said MRSA colonization and infections could be tracked among hospital patients and their household contacts to identify and mitigate transmission more effectively.
"This important study illustrates the risk of spread of resistant pathogens related to healthcare and highlights the essential importance of core infection practices," said SHEA President Thomas Talbot, M.D., chief hospital epidemiologist at Vanderbilt University Medical center. Talbot was not involved with the research. "Hand hygiene, environmental cleaning, and standard interventions to reduce Staphylococcal colonization are crucial to preventing the spread of resistant bacteria in healthcare settings."
Understanding MRSA
MRSA infections are known as superbugs because they do not respond to common antibiotics, making them difficult to treat. MRSA generally occurs in people who have been in a hospital or another healthcare setting, such as a nursing home, but MRSA also spreads in communities outside the hospital, usually through skin-to-skin contact. Most people with MRSA have no symptoms, but the bacteria can cause painful swelling if it gets under the skin, and it can be deadly if it spreads to other parts of the body, such as blood or lungs.
Researchers used a large database of insurance claims that included 158 million enrollees with two or more family members on the same plan to learn about how MRSA spread after someone in a household had been in the hospital.
Reviewing 424,512 MRSA cases among 343,524 insured people, the study found 4,724 cases of MRSA being potentially transmitted to a family member from a relative who had recently been in the hospital and had a diagnosis of MRSA. They also found 8,064 potential transmissions of MRSA after the hospitalization of a family member who did not have an MRSA infection.
"It is important not to over-emphasize the hospital stay risk," Miller said. "While we identified a significant risk factor for transmission in the household and community the absolute risk remains relatively low."
People exposed to a recently hospitalized family member with MRSA were more than 71 times, or 7000%, more likely to get an MRSA infection compared to enrollees who did not have a family member who had been hospitalized or exposed to MRSA in the previous 30 days.
Having a family member in the household who was hospitalized but did not have MRSA increased the chances of a relative getting MRSA in the month after discharge by 44%.
The more time the family member spent in the hospital, the higher the likelihood that someone in their household would get MRSA. If the patient was in the hospital for one to three days in the previous month, the chance of a relative getting MRSA increased by 34% compared to people with no recent hospitalizations in their household. If a family member was hospitalized for four to 10 days, the chances of MRSA infection in a relative were 49% higher, and with hospitalizations longer than 10 days the odds of a relative in the same household getting an infection rose by 70% to 80%.
Other factors associated with MRSA infections among household members included the number of other illnesses, prior antibiotic usage, and the presence of young children in the family.
Reference: "Hospitalizations among family members increase the risk of MRSA infection in a household" by Aaron C. Miller, Alan T. Arakkal, Daniel K. Sewell, Alberto M. Segre, Bijaya Adhikari, Philip M. Polgreen and For The CDC MInD-Healthcare Group, 7 August 2024, Infection Control & Hospital Epidemiology.
DOI: 10.1017/ice.2024.106
News
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]















